Addressing Global Health: WHO Confronts AIDS, Drugs, and the Future of Health

Harvard International Review, Summer 2004 | Go to article overview

Addressing Global Health: WHO Confronts AIDS, Drugs, and the Future of Health


The World Health Organization's (WHO) 3-by-5 initiative aims to treat 3 million people living with AIDS by the end of 2005. How does the initiative represent a change from past WHO efforts?

[ILLUSTRATION OMITTED]

The AIDS pandemic is one of the most difficult social, political, economic, and medical problems the world currently faces. AIDS represents the worst disease threat and the most serious social problem humankind has faced for many centuries. The 3-by-5 initiative is part of the global response, which includes prevention, treatment, and care. At the Barcelona AIDS Conference in 2002, the international community set the specific target of delivering treatment to 3 million people by the end of 2005. WHO, the Joint United Nations Programme on HIV/AIDS (UNAIDS), and other partners have put our weight behind this target, which is a key step on the way to universal access to treatment--the goal of our work.

What infrastructure is available for curbing the spread of AIDS in Africa? Are there social or cultural difficulties the WHO faces in establishing such infrastructure or in making such infrastructure efficient?

Building health systems and other infrastructure in developing countries is a vital part of the 3-by-5 initiative. Without strengthened health systems, this target cannot be achieved. However, this does not mean that brand-new hospitals and clinics need to be built all across Africa. Instead, WHO, UNAIDS, and our other partners are working to find innovative ways to involve community and other health workers in the delivery and monitoring of antiretroviral treatment for AIDS. This approach also has major potential benefits for other health problems, which require the availability of regular treatment from within the community. In a sense, everything WHO does is aimed at building more effective health systems to deliver better prevention, treatment, and care to people who need it.

How does the WHO balance "western" and "non-western" or individualized versus public approaches to medicine? Is the balance shifting?

Within WHO, there is a department that focuses on traditional medicine and the contribution such medicines can make to public health. This is not a question of "western" versus "non-western" approaches; rather, the key is to take the best evidence-based responses available and make them as widely available as possible.

What is the best way to minimize the cost of drugs and vaccines for the developing world? Is it more effective to provide drug patents or to fund public research and development?

There is no single answer. A combination of market-based solutions and public funding is needed to solve many health problems. Many partnerships already exist between the public and private sector to fund medicine provision as well as research and development. These include the Global Fund to Fight AIDS, TB and Malaria, the Global Alliance for Vaccines and Immunization, and the Special Programme for Research and Training in Tropical Diseases. Other programs, such as the Global Alliance for Leprosy Elimination, represent a collaboration between pharmaceutical companies and the public sector to provide innovative solutions to profound public health problems.

With what supranational or regional organizations in Africa, Asia, and the Middle East does the WHO collaborate?

WHO has many partnerships with public and private organizations in many parts of the world. We aim to work closely with any organization that has a serious interest in improving the delivery of health care, particularly in developing countries. The program to eradicate smallpox, which was completed successfully in the late 1970s, and the ongoing effort to eradicate polio are perhaps the best known and most successful examples of WHO partnership at work. Other partnerships with national governments, donors, nongovernmental organizations (NGOs) and private companies have also made major inroads in the fight against, for example, onchocerciasis (river blindness), leprosy, and other debilitating infectious diseases. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Addressing Global Health: WHO Confronts AIDS, Drugs, and the Future of Health
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.